Compound repurposing
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
Show/Hide Filters
Rubiginone D2 (HB4062)
Description:Antibiotic with antibacterial and antitumor activity
Purity:>98%
Tetrahydrobostrycin (HB4105)
Description:Antibiotic with antibacterial and anticancer activity
Purity:>97%
Trypacidin (HB4116)
Description:Antibacterial, antiprotozoal antibiotic. Necrosis inducer.
Purity:>98%